Dextran-Coated Carbon Nanotubes for Target-Specific Photothermal Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current photothermal therapies for treating inflammatory cells often result in unintended damage to non-target cells due to non-specific absorption and distribution of therapeutic materials within the body, leading to significant side effects and reduced therapeutic efficacy.

Innovation Solution

A composition of carbon nanotubes coated with dextran is developed for target-specific photothermal therapy, which selectively absorbs into inflammatory cells, allowing for thermotherapeutic action through external light irradiation without harming other cells, thereby minimizing side effects and maximizing therapeutic outcomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional photothermal therapy materials are used, then therapeutic effect on target cells is achieved, but non-specific damage to non-target cells occurs

Engineering Contradiction:
Improvetherapeutic effectVSAvoiddamage to non-target cells
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

Dextran serves as an intermediary coating on carbon nanotubes that mediates selective uptake by inflammatory cells through macrophage scavenger receptors, enabling target-specific accumulation while preventing non-specific distribution to other cells

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The carbon nanotubes are modified with dextran coating to create local quality differences, making them specifically recognizable and uptakeable by inflammatory cells while remaining inert to other cell types, thus achieving spatially selective therapeutic action

Inventive Principle:
Principle #3Local quality

2Temperature

If photothermal materials are accumulated in body tissue, then therapy depth is increased, but non-specific distribution to non-target cells occurs

Engineering Contradiction:
Improvetherapy depthVSAvoidnon-specific distribution
Core Design Contradiction:
TemperatureVSObject-affected harmful factors

Solution Approach 1:

Dextran coating acts as a mediator that directs nanotube accumulation specifically to inflammatory cells via scavenger receptor binding, preventing non-specific distribution while maintaining deep tissue penetration capability through near-infrared light activation

Inventive Principle:
Principle #24Intermediary (Mediator)

3Reliability

If therapeutic particles are accumulated in cancer cells, then target specificity is improved, but selective uptake mechanism complexity increases

Engineering Contradiction:
Improvetarget specificityVSAvoiduptake mechanism
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

Dextran serves as a natural intermediary that exploits the existing macrophage scavenger receptor system, providing simple yet specific target recognition without requiring complex engineered targeting moieties or multiple component systems

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The dextran-coated nanotubes utilize the body's own scavenger receptor system on inflammatory cells for selective uptake, allowing the therapeutic agent to self-direct to target cells through natural biological recognition mechanisms rather than requiring external guidance systems

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dextran-coated carbon nanotubes effectively target and kill inflammatory cells while sparing other cells, achieving enhanced therapeutic effects with reduced side effects, as demonstrated by experiments showing specific cell uptake and temperature increases only in the presence of NIR laser irradiation.

Implementation Method 1

accumulating a material generating heat by absorbing light in a near infrared area

Methodology Applied
Scientific EffectLight absorption: Absorption (EM radiation)

Implementation Method 2

causes thermotherapeutic action through light irradiated from an external light source

Methodology Applied
Scientific EffectPhotothermal conversion:

Implementation Method 3

the composition may selectively kill only the cells to be treated by using carbon nanotubes coated with dextran

Methodology Applied
Scientific EffectSelective cellular uptake: Absorption (physical)

Data Source

PatentUS10617760B2Composition for target-specific photothermal therapy
Publication Date: 2020.04.14 GACHON UNIV OF IND ACADEMIC COOPERATION FOUND
  • US10617760B2 patent drawing
  • US10617760B2 patent drawing
  • US10617760B2 patent drawing

AI summary

Provided are a composition for target-specific photothermal therapy and a method of photothermal therapy using the composition and more particularly, a method of photothermal therapy for selectively killing inflammatory cells by using the composition for target-specific photothermal therapy comprising carbon nanotubes coated with dextran.According to the present invention, the composition for photothermal therapy comprising the carbon nanotubes coated with dextran is absorbed only into desired target cells, i.e., inflammatory cells, and causes thermotherapeutic action through light irradiated from an external light source, while not damaging cells except for inflammatory cells. The method of photothermal therapy using the composition for photothermal therapy has advantages of minimizing side effects and maximizing therapeutic effects.